BiotechTube

carbidopa/levodopa + Carbidopa/Levodopa/Entacapone

ApprovedWithdrawn
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Parkinson's Disease

Conditions

Parkinson's Disease

Trial Timeline

Aug 1, 2008 → Nov 1, 2009

NCT ID
NCT00601978

About carbidopa/levodopa + Carbidopa/Levodopa/Entacapone

carbidopa/levodopa + Carbidopa/Levodopa/Entacapone is a approved stage product being developed by Novartis for Parkinson's Disease. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00601978. Target conditions include Parkinson's Disease.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson's Disease were approved

Approved (20) Terminated (3) Active (0)
✅Lemborexant + placeboEisaiApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved
✅carbidopa, levodopa, entacaponeNovartisApproved
✅Levodopa/carbidopa/entacapone + Levodopa/carbidopaNovartisApproved
✅Cabergoline + LevodopaPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00601978ApprovedWithdrawn

Competing Products

20 competing products in Parkinson's Disease

See all competitors
ProductCompanyStageHype Score
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
GPI 1485EisaiPhase 2
35
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
E2007 + E2007 + E2007EisaiPhase 2
35
E2007EisaiPhase 2
35
E2007EisaiPhase 2
27
E2007EisaiPhase 2
27
2 mg perampanel + 4 mg perampanel + placebo comparatorEisaiPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 2
35
Istradefylline 20 mg or 40 mgKyowa KirinPhase 3
40
Istradefylline (KW-6002)Kyowa KirinPhase 3
40